Werewolf Therapeutics, Inc. Common Stock
Symbol: HOWL (NASDAQ)
1.48
▲ (2.07%) 0.030
Company Description:
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
Key Stats
- Today's Open: $1.5
- Today's High: $1.545
- Today's Low: $1.455
- Today's Volume: 371.55K
- Yesterday Close: $1.45
- Yesterday High: $1.51
- Yesterday Low: $1.4405
- Yesterday Volume: 599.09K
- Last Min Volume: 1.23K
- Last Min High: $1.48
- Last Min Low: $1.48
- Last Min VWAP: $1.48
Company Profile
- Name: Werewolf Therapeutics, Inc. Common Stock
- Website: https://www.werewolftx.com
- Listed Date: 2021-04-30
- Location: WATERTOWN, MA
- Market Status: Active
- CIK Number: 0001785530
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $68.14M
- Round Lot: 100
- Outstanding Shares: 45.73M
- Asset Type: CS
RECENT FILINGS FOR HOWL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-05-15 | EFFECT | View |
| 2025-05-15 | 8-K | View |
| 2025-05-14 | SCHEDULE 13D/A | View |
| 2025-05-14 | 4 | View |
| 2025-05-13 | CORRESP | View |
| 2025-05-12 | UPLOAD | View |
| 2025-05-08 | S-3 | View |
| 2025-05-08 | S-8 | View |
| 2025-05-08 | 10-Q | View |
Latest News on HOWL